833451-96-0Relevant articles and documents
Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways
Chakrabarty, Suravi,Monlish, Darlene A.,Gupta, Mohit,Wright, Thomas D.,Hoang, Van T.,Fedak, Mitchel,Chopra, Ishveen,Flaherty, Patrick T.,Madura, Jeffry,Mannepelli, Shankar,Burow, Matthew E.,Cavanaugh, Jane E.
, p. 2294 - 2301 (2018/05/28)
-
METHODS OF PREPARING MEK INHIBITOR
-
Page/Page column 11; 15, (2008/06/13)
This invention relates to methods of preparing MEK inhibitor N-[(R)-2,3-dihydroxy-propoxy]-3,4- difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide that useful for treating diseases mediated by MEK activity in mammals. The present invention provides new synthetic routes that are safe, efficient and cost effective when carried out on a commercial scale.